Sustaining the implementation of an evidence-based guideline for bronchiolitis

Archives of Pediatrics and Adolescent Medicine

Volumn 154, Issue 10, 2000, Pages 1001-1007

  Perlstein, Paul H ^a   Kotagal, Uma R ^a,b   Schoettker, Pamela J ^a   Atherton, Harry D ^a   Farrell, Michael K ^a   Gerhardt, Wendy E ^a   Alfaro, Mary Pat ^a  

^a Children's Hospital Medical Center   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT;

AEROSOL; ARTICLE; BRONCHIOLITIS; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; DOSE RESPONSE; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE DELIVERY; HOSPITAL ADMISSION; HOSPITAL BED UTILIZATION; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; PATIENT CARE; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY CARE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; THORAX RADIOGRAPHY;

EID: 0033803002     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.154.10.1001     Document Type: Article

References (36)

1. Evaluation of an evidence-based guideline for bronchiolitis
2. Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations
3. Use of clinical practice guidelines in managed care physician groups
4. Screening guidelines in a family medicine program: A five-year experience
5. The adoption of preventive care practice guidelines by primary care physicians: Do actions match intentions?
6. Evaluation of a pneumonia practice guideline in an interventional trial
7. Randomized trial of salbutamol in acute bronchiolitis
8. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis
9. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis
10. Alpha and beta adrenergic stimulants in bronchiolitis and wheezy bronchitis in children under 18 months of age
11. Recent advances in the treatment of bronchiolitis and laryngitis
12. The distinction between cost and charges
13. StandArdizing the care of bronchiolitis
14. Update respiratory syncytial virus activity-United States, 1997-98 season season
15. Acute viral bronchiolitis in infancy: Epidemiology and management
16. Effect of salbutamol on oxygen saturation in bronchiolitis
17. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants
18. Hypoxaemia in wheezy infants after bronchodilator treatment
19. Bronchiolitis in children
20. Efficacy of albuterol in the management of bronchiolitis
21. Oral versus nebulized albuterol in the management of bronchiolitis in Egypt
22. The role of bronchodilators in the mangement of bronchiolitis: A clinical trial
23. The use of albuterol in hospitalized infants with bronchiolitis
24. Albuterol in acute bronchiolitis: Continued therapy despite poor response?
25. Effect of salbutamol on respiratory mechanics in bronchiolitis
26. Efficacy of beta2-agonists in bronchiolitis: A reappraisal and meta-analysis
27. Pediatric emergency medicine practice patterns: A comparison of pediatric and general emergency physicians
28. Bronchial asthma and hyperreactivity after early childhood bronchiolitis or pneumonia: An 8-year follow-up study
29. Bronchial asthma after early child-hood wheezing: A follow-up until 4.5-6 years of age
30. Serum eosinophil cationic protein as a predictor of wheezing after bronchiolitis
31. Bronchiolitis in the history of the asthmatic child
32. Bronchial hyperreactivity and history of wheezing in children
33. Why don't physicians follow clinical practice guidelines? A framework for improvement
34. Bronchiolitis-associated hospitalizations among US children, 1980-1996
35. Evaluation of a pediatric hospitalist service: Impact on length of stay and hospital charges